Programs

Sharing Knowledge that Leads to Innovation

The Institute relies on three basic tenets in its approach to improving medical product development: "faster, safer and smarter." Our programs support the FDA's Critical Path Initiative and were developed with detailed input from scientists from the FDA, industry and academia.

Although C-Path's work can be looked at as a series of projects funded by grants and performed by collaborations and consortia, the work generally falls under the goal of creating methods to enable personalized medicine that improves the public health.

Resulting Tools

• Biomarkers and methods qualified by the FDA for use in medical product development
• A process for co-development of a drug and a companion diagnostic test